Benzinga | Apr 20, 2021 08:30AM EDT

Roth Capital Maintains Buy on Fortress Biotech, Raises Price Target to $5

Roth Capital maintains Fortress Biotech (NASDAQ:FBIO) with a Buy and raises the price target from $4.5 to $5.